Wein, Marc Nathan
- Massachusetts General Hospital · Internal Medicine (investigator's affiliation)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,381
- Rising Star
- Program Leader
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2013 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.1M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#3,381
By linked amount among FY2023 PIs
Earliest Year Loaded
2013
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Wein, Marc Nathan as a PI. Multi-PI records show the full award amount for context.
- 1P50AR080596-01P50Contact PICenter of Research Translation on Osteoporosis Bone Anabolic TherapiesMassachusetts General Hospital · Internal Medicine (investigator's affiliation)$1.7Maward amount
- 2R01DK116716-06A1R01Contact PIThe role of salt inducible kinases in parathyroid hormone action in boneMassachusetts General Hospital · Internal Medicine (investigator's affiliation)$442.5Kaward amount
Award organization
Organizations that administered FY2023 awards listing Wein, Marc Nathan as a PI.
FY2023 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2013First NIH AwardMassachusetts General Hospital
- 2016R01 Grant Holder
- 2017$500K Cumulative Funding
- 2018$1M Cumulative Funding
- 2018Program/Center Grant Leader
- 2021$2M Cumulative Funding
- 2023Entered Top 50% NationallyRanked #3381
- 2023Entered Top 25% NationallyRanked #3381